By a News Reporter-Staff News Editor at Life Science Weekly — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Igi Laboratories, Inc. (Form 424B5) was posted on June 27, 2014.
The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).
There were 2 documents filed with this form. The SEC file number is 0001571049-14-002701.
The contact information for this company is 105 LINCOLN AVENUE, BUENA NJ 08310, 6096971441.
Our editors provided additional information about Form 424B5: Prospectus filed pursuant to Rule 424(b)(5).
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/352998/0001571049-14-002701-index.html.
Keywords for this news article include: SEC Filing, Biological Products, Igi Laboratories Inc., (No Diagnostic Substances).
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Read Next
